Purpose: Visualization of endolymphatic hydrops by 3-dimensional ‰uid-attenuated inversion recovery-FLAIR using conventional turbo-spin-echo (3D-FLAIR-CONV) after intratympanic injection of Gd-DTPA has been reported in patients with M áeni àere's disease. Compared to 3D-FLAIR-CONV used in previous studies, the addition of a variable ‰ip-angle technique (3D-FLAIR-VFL) enables very long echo trains and, therefore, shorter scan times. We evaluated whether 3D-FLAIR-VFL could replace 3D-FLAIR-CONV in detecting endolymphatic hydrops after intratympanic Gd-DTPA administration.
Introduction
Visualization of endolymphatic hydrops by magnetic resonance (MR) imaging after intratympanic injection of gadolinium-diethylene-triamine pentaacetic acid (Gd-DTPA) has recently been reported in patients with M áeni àere's disease. In these patients, on 3-dimensional ‰uid-attenuated inversion recovery (3D-FLAIR) obtained with a conventional turbo spin-echo sequence after intratympanic injection of Gd-DTPA at 3T, the enlarged endolymphatic space without Gd-DTPA distribution has been recognized as an area of low signal intensity partly surrounded by high-signal perilymphatic ‰uid with Gd-DTPA distribution. 1 Although the inplane resolution was relatively high at 0.42 mm× 0.42 mm, the scan time was rather long, 15 min, even when applying a parallel imaging technique and utilizing slices 2-mm thick.
On the other hand, 3D-FLAIR covering the entire labyrinth can be obtained in 5 to 6 min with a near isotropic resolution of 0.67 mm×0.67 mm× 0.8 mm by using a variable ‰ip-angle turbo-spinecho (3D-FLAIR-VFL) technique. 2 This voxel volume is almost identical to that of the conventional turbo-spin-echo 3D-FLAIR (3D-FLAIR-CONV) used in previous studies. 1, 3 The shorter scan time of 3D-FLAIR-VFL enables its routine use in clinical settings. Thus, 3D-FLAIR-VFL has been used to evaluate various inner ear disorders. [4] [5] [6] [7] [8] [9] [10] The pre-contrast 3D-FLAIR-VFL scan was used to detect subtle changes in labyrinthine ‰uid composition, and the post-contrast 3D-FLAIR-VFL scan (following intravenous Gd-DTPA administration) was used to detect disruption of the blood labyrinthine barrier. 4, 8 We evaluated whether 3D-FLAIR-VFL could replace 3D-FLAIR-CONV for detecting endolymphatic hydrops after intratympanic Gd-DTPA administration.
Materials and Methods

Patients
Eleven patients (5 men, 6 women, aged 24-74; eight with clinically diagnosed M áeni àere's disease, one with sudden sensorineural hearing loss, one with ‰uctuating sensorineural hearing loss, and one with delayed endolymphatic contralateral-type hydrops) underwent intratympatic administration of gadolinium-diethylene-triamine pentaacetic acidbis (methylamide) (Gd-DTPA-BMA; Omniscan, Daiichi-Sankyo Pharmaceutical Co. Ltd., Tokyo, Japan). These patients were scheduled for intratympanic injection therapy with gentamicin or, for the patient with sudden sensorineural hearing loss, a steroid. Written informed consent was obtained from all patients. This study was approved by the institutional review board of our university hospital.
Intratympanic gadolinium injection
The detailed methods for intratympanic gadolinium injection have been reported. 1 In that study, a delay of 24 hours between the intratympanic gadolinium injection and MR imaging was found to be optimal to allow the gadolinium to distribute widely in the perilymphatic space of the labyrinth.
Gd-DTPA-BMA was diluted 8-fold with saline (v/v 1:7) and injected intratympanically using a 23-G needle and a 1-mL syringe after the patient was placed in the supine position with head turned approximately 309 away from the sagittal line toward the healthy ear. The diluted Gd-DTPA-BMA was injected until a back‰ow of ‰uid into the external ear was observed through a microscope, resulting in an injected volume of 0.4 to 0.5 mL per patient. After the injection, the patient remained in the supine position for 60 min with head turned approximately 609away from the sagittal line toward the healthy ear. Gentamicin or steroid was not injected at the same time.
MR imaging
All scans were performed on a 3T MR imaging scanner (MAGNETOM Trio, Siemens Medical Solutions; Erlangen, Germany) using a receive-only, 12-channel, phased-array coil. T1-weighted 3D-FLASH (fast low-angle shot) and 3D-FLAIR-CONV images were acquired 24 hours after intratympanic injection of diluted Gd-DTPA-BMA.
In addition, T2-weighted 3D-CISS (constructive interference in the steady state) imaging was performed to obtain reference images of the labyrinthine ‰uid-space anatomy.
The The parameters for 3D-FLAIR-VFL were: TR, 9000 ms; eŠective TE, 638 ms; variable ‰ip-angle echo train with an average ‰ip angle, 151 degrees; echo-train length, 171; matrix size, 384×384; 48 axial 0.8-mm-thick slices covering the labyrinth; FOV, 25.6 cm 2 ; acceleration factor, 2 using the GRAPPA technique; 11 voxel size, 0.67 mm×0.67 mm×0.8 mm; and NEX, 2. The total scan time was 5 min 26 s. The readout bandwidth was 592 Hz/pixel, and the echo spacing was 3.64 ms. Nonselective inversion pulses and slab-selective excitation pulses were used. The features of this variable ‰ip-angle sequence have been reported elsewhere. [12] [13] [14] This sequence allows the use of very long echo-train lengths, in the range of 150 to 220, without severe blurring and while maintaining contrast similar to that of 3D-FLAIR-CONV, even with a long eŠective echo time. To achieve short echo spacing,ˆeld of view was larger than with other sequences.
Image evaluation Qualitative evaluation
The size of the endolymphatic space in the vestibule was scored subjectively: a score of 3 indicated that the entire vestibule was occupied by endolymph; 2, more than half was occupied by endolymph; 1, from 30 to 50z was occupied by endo-lymph; and 0, less than 30z was occupied by endolymph.
The size of endolymphatic space in the cochlear basal turn was scored subjectively: 3: the cochlear duct was larger than the perilymphatic space of the scala vestibule; 2: Reissner's membrane was bulging toward the scala vestibuli, though smaller than the perilymphatic space of the scala vestibule; 1: no bulging of Reissner's membrane; and 0: bulging of Reissner's membrane toward the scala media or no visualization of endolymphatic space. Two radiologists independently scored the size of the endolymphatic space. 3D-FLAIR-CONV and 3D-FLAIR-VFL were evaluated separately with an interval of 7 days. If a discrepancy existed between the two, consensus was obtained after discussion.
The probability of endolymphatic hydrops was scored tentatively from clinical records: 3, high; 2, moderate; 1, slight; and 0, low. This probability was scored subjectively based on the ratio of the summating potential to the action potential (SP/AP) on an electrocochleogram, 15, 16 the vestibular evoked myogenic potential (VEMP), 17 audiogram frequency and ‰uctuation patterns, and clinical history. A positive VEMP response is considered to be a normal sign of vestibular function, especially for the saccule. 16 An SP/AP ratio larger than 36z is considered to be positive for cochlear endolymphatic hydrops. 16 However, because concrete diagnosis of endolymphatic hydrops is not possible, this probability score is not a perfect standard of reference.
Quantitative evaluation
The contrast-to-noise ratio (CNR) between the basal turn of the cochlea and the cerebellum was measured by drawing a circular region of interest (ROI) in the basal turn of the cochlea, in the cerebellum, and in air. The ROI diameter of the cochlea was 2 mm, and the ROI diameters of the cerebellum and air were 6 mm. The CNR value was dened as the diŠerence in signal between the cochlea and cerebellum divided by the standard deviation of the air signal. CNR per scan time was deˆned as the CNR value divided by the square root of the scan time. CNR and CNR per scan time values were compared using student's t-test.
Results
No side eŠects related to the intratympanic injection were observed.
Table summarizes patients and evaluation results. On T1-weighted 3D-FLASH, contrast enhancement in the labyrinth was quite faint in all patients; therefore, 3D-FLASH images were not used for further evaluation.
Image evaluation Qualitative analysis
The scores for the size of the endolymphatic space in the vestibule were identical between the 2 sequences (Fig. 1) . On the other hand, the scores for the size of the endolymphatic space in the cochlea disagreed in 3 cases (Fig. 2) . In these 3 cases, 3D-FLAIR-VFL showed a score of 0 for the patients with a positive probability score.
Quantitative analysis
The CNR between the basal turn of the cochlea and the cerebellum was signiˆcantly higher with 3D-FLAIR-CONV (34.1＋/-21.5) than with 3D-FLAIR-VFL (21.1＋/-18.2) (Pº0.01); however, CNR per scan time was not signiˆcantly diŠerent.
Discussion
Intratympanically injected Gd-DTPA is thought to be absorbed through round window membrane into labyrinthine space. 1 Gd-DTPA distributes mainly in the perilymph space, allowing separate visualization of the endo-and perilymph space. 1 A variable ‰ip-angle turbo-spin-echo (VFL) sequence enabled the acquisition of images with a very long echo train (À100) and very long eŠective echo time (À300 ms) while keeping T2-contrast and blurring at levels similar to that using a conventional turbospin-echo sequence with an echo train length of 15 to 30. 12, 13 A VFL sequence using a non-selective excitation pulse can image the whole brain with 1-mm isotropic resolution in a scan time of several minutes. 13 However, the 3D-FLAIR-VFL protocol employed in the present study used a slab-selective excitation pulse to reduce the imaged volume and scan time while obtaining sub-millimeter isotropic voxels.
This slab-selective 3D-FLAIR-VFL protocol can obtain images with a voxel volume comparable to that of 3D-FLAIR-CONV in a far shorter scan time. Scan time of 15 min by 3D-FLAIR-CONV is too long to include in routine practice in most hospitals. However, the CNR of cochlear ‰uid was signiˆcantly lower on 3D-FLAIR-VFL, and the inplane acquisition spatial resolution was also lower. The eŠective in-plane resolution may be lower still as a result of blurring induced by the very long echo train, even though the variable ‰ip-angle technique reduces blurring compared to a constant ‰ip-angle echo train of the same length.
It might have been possible to compare reformatted 2-mm-thick 3D-FLAIR-VFL images made from 0.8-mm-thick data and 2-mm-thick 3D-FLAIR- SP/AP＝summating potential/action potential on electrocochleography VEMP＝vestibular evoked myogenic potential 3D-FLAIR-CONV＝3-dimensional ‰uid-attenuated inversion recovery (FLAIR) using conventional turbo-spin-echo 3D-FLAIR-VFL＝3-dimensional ‰uid-attenuated inversion recovery (FLAIR) using variable ‰ip-angle technique Fig. 1 . A 46-year-old man with M áeni àere's disease. On both 3-dimensional ‰uid-attenuated inversion recovery using conventional turbo-spin-echo (3D-FLAIR-CONV) (a) and using variable ‰ip-angle technique (3D-FLAIR-VFL) (b), the size of the endolymphatic space in the cochlea (arrows) and vestibule (short arrows) were scored as 3, although endolymphatic space in the cochlea is more clearly depicted on 3D-FLAIR-CONV. Almost no Gd-DPTA is seen in the vestibule in this case, whereas the vestibule isˆlled with lymphatic ‰uid on 3D-constructive interference in the steady state (CISS) (short arrows, c). On T1-weighted 3D-fast low-angle shot (FLASH) (d), signal enhancement of perilymphatic ‰uid is quite faint; thus the discrimination between perilymph and endolymph is impossible. CONV. However, increasing the reconstruction slice thickness of 3D-FLAIR-VFL would have resulted in the further degradation of the performance by 3D-FLAIR-VFL because the newly reconstructed voxel size of 3D-FLAIR-VFL was far larger than that of 3D-FLAIR-CONV.
The performance of 3D-FLAIR-VFL in detecting endolymphatic hydrops in the vestibule was comparable to that of 3D-FLAIR-CONV. In the cochlea, however, the 3D-FLAIR-CONV protocol was better, probably because of its higher in-plane resolution and higher CNR, as stated in the previous paragraph. The diameter of the cochlear duct (cochlear endolymphatic space) is smaller than the dimensions of the endolymphatic space in the vestibule, and the cochlear duct is in contact with surrounding bone tissue. Therefore, the recognition of endolymphatic hydrops in the cochlea might be more di‹cult than in the vestibule.
In the present study, we tried to reduce the scan time by a factor of 3 using 3D-FLAIR-VFL, which resulted in some image degradation. However, a Fig. 2 . A 50-year-old woman with ‰uctuating sensorineural hearing loss in the right ear. On 3-dimensional ‰uid-attenuated inversion recovery using conventional turbo-spin-echo (3D-FLAIR-CONV) (a), the size of endolymphatic space in the cochlea (arrow) was scored as 2; on 3D-FLAIR using variable ‰ip-angle technique (VFL) (b), however, it was scored as 0 (arrow). This is probably due to the lower in-plane resolution and more blurring of 3D-FLAIR-VFL compared with 3D-FLAIR-CONV. The probability of endolymphatic hydrops from clinical records in cochlea was scored as 2.
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factor-of-2 reduction, for example, might have been more practical. Further study is needed to determine a practical degree of scan time reduction. The application of further technical developments also might improve the performance of 3D-FLAIR-VFL. For example, a T2-selective inversion recovery scheme may provide a more time-e‹cient scan, 18 and the introduction of a 32-channel head array coil would improve the signal-to-noise ratio and thereby allow higher parallel imaging factors. 19 In the present study, we reviewed the images only in the axial orientation. However, 3D-FLAIR-VFL had a higher spatial resolution in the z-direction than did 3D-FLAIR-CONV. The results might have been in‰uenced if we had reviewed coronal or sagittal reformatted images, in addition to the original axial images.
One limitation of this study was the lack of a concrete standard of reference. We arrived at a tentative probability score for endolymphatic hydrops based not only on patient symptoms and history, but also on the results of objective tests such as the electrocochleogram and VEMP. However, it is di‹cult to evaluate the feasibility of using this score. In some cases, the results of the electorocochleogram and/or VEMP disagreed with clinical symptoms and disease history. The guidelines for M áeni àere's disease from the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) Committee of Hearing and Equilibrium dene M áeni àere's disease mostly in terms of its symptoms, 20, 21 describing the probability of the disease as possible, probable, deˆnite, and certain. Certain M áeni àere's disease is deˆned as deˆnite with histopathologic conˆrmation; objective diagnosis with histological conˆrmation is currently virtually impossible. To make the diagnosis of certain M áeni àere's disease in the future, MR imaging may be a desirable replacement for histological conˆr-mation.
It would be very interesting if changes in 3D-FLAIR imageˆndings were found to correlate with therapy-induced changes in the symptoms of endolymphatic hydrops. An individual longitudinal study might be useful to conˆrm the feasibility of this method in detecting and evaluating endolymphatic hydrops in vivo.
To compare the performance of 3D-FLAIR-VFL and 3D-FLAIR-CONV directly, a phantom simulating the actual dimensions of labyrinthine anatomy as well as the Gd-DTPA concentrations of labyrinthine endolymph and perilymph would also be helpful.
Conclusions
3D-FLAIR-VFL can obtain images with a voxel volume comparable to that of 3D-FLAIR-CONV and detect endolymphatic hydrops of the vestibule at a similar rate in a scan time that is nearly a factor of 3 shorter. However, the performance in detecting endolymphatic hydrops of the cochlea was lower with 3D-FLAIR-VFL. Thus, we currently may not be able to replace 3D-FLAIR-CONV with 3D-FLAIR-VFL, at least not with the scanning parameters used in the present study.
